Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Post-Year End Highlights: * Production has completed on "The Veteran" with presales of almost $1million achieved * "The Veteran" will be screened at the Berlin Film Festival in February 2011 and released in the UK in April 2011 * Shooting for "Ecstasy" started in December in Canada. "Ecstasy" is based on the Irvine Welsh novel and is generally considered to be the follow up to "Trainspotting". * "Ecstasy" is expected to premiere at the Toronto Film Festival in September 2011.
* Earnings per share 3.72p (2009: 2.29p loss per share) * Operating loss reduced to £642,047 (2009: £991,593) * Number of films represented more than doubled from 14 to 30, compared with the previous year * Appointed as Executive Producer and international sales company to 20 new films with total budgets in excess of £150m
Highlights: * Net profit after tax of £3.31m (2009: £1.9million loss) * £5.7m loan eliminated from balance sheet at net profit of £3.92m * Earnings per share 3.72p (2009: 2.29p loss per share)
Looking at the way this operation is growing it is a surprise to see the mark cap still only at £3.7M. The scope for dramatic increase is enormous.
Intandem is working on the financing for a slate of over 15 films with total budgets in excess of £100million for 2011 and expects to make further exciting announcements on its slate shortly.
30th November 2010 Analyst: Jon Levinson Email: jon.levinson@gecr.co.uk Tel: 020 7562 3357 Intandem Films* - Pre Results Comment: Buy at 3p with a 7p price target Key Data EPIC IFM Share Price 3p NMS 1,000 Spread 2.75p-3.25p Total no of Shares 105.68 million Market Cap GBP3.17 million 12 Month Range 0.5p-4.25p Market AIM Website www.intandemfilmsplc.com Sector Media Contact Gary Smith Chief Executive 020 7851 3800
Pleased to see there is at last someone else interested in IFM on this board. I have held these for a few years now and things appear to be taking shape. The quality of the films has improved - with some highly regarded names in play - not to mention Andrew Brown who's reputation brought me to invest in the first place. As far as I understand it much of the income is through an accumulated share of the sales proceeds which means a long term view is needed - and of course - patience. I think we are very much at a critical stage with exposure to the high end film market. Big gains to be had and as we investors have waited - let's hold on and reap the rewards ! There are not too many shares in issue and when this finally gets above the radar I think we could see some pretty dramatic sp movements. Fireworks are inevitable when shares are in demand and only a few are available in the market. GLA
djusted net assets of £198.6m (31 March 2010: £186.5m), equivalent to 64.8p (31 March 2010: 60.9p) per Share
Andrew Brown, Director at Intandem, commented: "The Veteran is a bold film shot in London and was welcomed at the American Film Festival. We were overwhelmed by the response received and are delighted to be working with all the distributors, especially Revolver, which has very exciting plans for the cinema release of the film in Spring 2011. We are excited about selling the film to further markets around the world upon its completion, starting with the Berlin Film Festival in February 2011, and are confident in its success."
pleased to announce that it has sold the UK rights to London Shot Action Thriller, 'The Veteran' starring Toby Kebbel ('Prince of Persia') and Brian Cox ('Troy' and the 'Bourne Supremacy'), to Revolver Entertainment, one of the UK's leading 'All Rights' distribution companies. The film is expected to be released in UK cinemas in Spring 2011. The rights to 'The Veteran', which is currently in post production, have also been sold to Pinnacle Films for Australia, California Films for Brazil, Audio Visual Enterprises for Greece and Falcon Films for the Middle East, based on the script and a trailer produced by Intandem. Intandem Films is the Worldwide Sales Company of the film, which has been financed by private equity.
§ Re-instatement of dividend; 1p per share declared § Group revenues up 16.3% to £30.7m (H1 2009: £26.4m) § Group operating profit from continuing operations up 122.7% to £16.7m (H1 2009: £7.5m) § Pharmacy revenues increased 10.5% to £16.8m2 (H1 2009: £15.2m). Same store revenues increased 7.2% (for stores open throughout both periods) § Pharmacy operating profit £1.4m (H1 2009: Loss of £0.1m) § LIFT consultancy revenues increased 120% to £2.2m (H1 2009: £1.0m) § Net cash inflow from operating activities £4.6m (H1 2009: outflow £6.4m) § Administration expenses from continuing operations reduced by 14.4% from £9.0m in H1 2009 to £7.7m despite growth in revenues § Adjusted net assets of £198.6m (31 March 2010: £186.5m), equivalent to 64.8p (31 March 2010: 60.9p) per Share3 § Debt repayments of only £4.5m required prior to March 2013 § £35.3m4 cash in hand at year end (31 March 2010: £24.6m)
At last - been in here waiting for the pick up in sentiment for private firms to filter through here. As the private sector recovery filters through firms need accommodation and prefer a the type of flexible arrangements offered by MWB. I think this will now increase steadily as market conditions continue to improve for private firms looking to rent space for expansion
Level 2 volume shows 630k v 219k. Currently 21.25/ 21.75p at 25819 v 14956. Just confirms my convictions on this one.
Continuing good news should lead to further steady increases. I still think this is way indervalued. And have a look at the dividend !!! At nearly 10% who would rather have their money in the bank ? I can see this heading steadily to 30p and beyond over the coming months as market conditions improve. A victim of overselling in the downturn means rich pickings for the astute investor. Get in quick before the others realise the missed opportunity.
looking good today !!!
26% up today !!!